Milestone Scientific CEO Interview: Game-Changing Injection Technology
Investing - Small-Cap Market Intelligence • 13m
Watch our exclusive interview with Milestone Scientific (NYSE American: MLSS) CEO Leonard Osser. Milestone Scientific is a biomedical technology research and development company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone's computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone's proprietary DPS Dynamic Pressure Sensing technology® platform advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures, and intra-articular joint injections.
Up Next in Investing - Small-Cap Market Intelligence
-
CIIX High Growth Investment Opportuni...
ChineseInvestors.com (OTCQB: CIIX) has built a large base of Chinese-speaking consumers over its 20-year history. Since its founding in 1999, the company focused on providing financial news and information through its proprietary platform ChineseInvestors.com, which continues to generate subscrip...
-
Can-Fite BioPharma Ltd. (NYSE America...
Can-Fite BioPharma Ltd. (NYSE American: CANF) is an advanced clinical-stage drug development company with a platform technology that addresses multi-billion-dollar markets in the treatment of autoimmune inflammatory diseases including Rheumatoid Arthritis and Psoriasis, and liver diseases includi...
-
Ethema Health: New Paradigm in Mental...
Ethema Health Corporation (OTCQB: GRST) operates in the behavioral healthcare space, specifically in the treatment of substance-use disorders. The company has developed a unique treatment model that has shown to be highly effective at treating opioid addiction. Launched in 2011, Ethema plans to o...
